Stay updated with breaking news from Csl Behring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MARBURG, GERMANY The new facility, once fully open later this calendar year, will be CSL’s largest R&D site under one roof, with more than 500 team members working in a state-of-the-art facility offering access to promising scientific partners and talent.
BrightInsight developed the Disease Management Solution to help biopharma and medtech companies bring their Software as a Medical Device (SaMD) to market faster, according to BrightInsight CEO and Co-founder Dr. Kal Patel.
/PRNewswire/ -- Global biotherapeutics leader CSL Behring and renowned portrait photographer Rankin have teamed up to launch 'Portraits of Progress', a...
The 500 million international units (IUs) will include product specifically manufactured for donation allowing for a longer shelf life and enabling more people around the world to access life-saving therapy.
/PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced positive long-term results from the Phase 3 HOPE-B clinical trial evaluating...